Loading product details…Cargando detalles del producto…Carregando detalhes do produto…

At a glance

AGORESEARCH
Specification
Category
Form
Knowledge source
Research focus
Reconstitution
Storage
COA

What is BBKG80?

Four-peptide repair blend profile with anti-inflammatory KPV. The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg is mapped to LPPeptide SKU BBKG80. Current storefront values use our product data: 80mg x 10 vials /box, $205.00 USD per box. LPPeptide reference specs: 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu).

Research context

The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. Reference context combines TB-500 tissue repair, BPC-157 regenerative signaling, KPV inflammatory-pathway literature, and GHK-Cu collagen and wound-model literature.

Commonly matched with

BBKG80 is commonly reviewed alongside BC10, BB10, BB20, BT10, BPC-157. Keep each combination tied to a defined research objective and lot record.

Compliance notice

BBKG80 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. Reference context combines TB-500 tissue repair, BPC-157 regenerative signaling, KPV inflammatory-pathway literature, and GHK-Cu collagen and wound-model literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu).

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL bacteriostatic water for about 26.7 mg/mL. Component concentrations are TB-500, BPC-157, and KPV about 3.33 mg/mL each, with GHK-Cu about 16.7 mg/mL. Reference amount is about 2.67 mg daily for 4 weeks; 1 U is about 2.67 mg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL bacteriostatic water for about 26.7 mg/mL. Component concentrations are TB-500, BPC-157, and KPV about 3.33 mg/mL each, with GHK-Cu about 16.7 mg/mL. Reference amount is about 2.67 mg daily for 4 weeks; 1 U is about 2.67 mg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8 deg C, or -20 deg C for long-term storage. Reconstituted: 2-8 deg C, use within about 4 weeks, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Blend safety data is limited compared with single materials. Review every component and keep adverse observations separated by study arm.

Contraindications

Do not use BBKG80 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Avoid additional repair or anti-inflammatory stacks unless the protocol explicitly justifies each component.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps BBKG80 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: BBKG80
  • Product: TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg
  • Storefront specification: 80mg x 10 vials /box
  • LPPeptide reference specs: 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu)
  • Listed box price: $205.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is BBKG80?

Four-peptide repair blend profile with anti-inflammatory KPV. The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg is mapped to LPPeptide SKU BBKG80. Current storefront values use our product data: 80mg x 10 vials /box, $205.00 USD per box. LPPeptide reference specs: 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu).

Research context

The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. Reference context combines TB-500 tissue repair, BPC-157 regenerative signaling, KPV inflammatory-pathway literature, and GHK-Cu collagen and wound-model literature.

Commonly matched with

BBKG80 is commonly reviewed alongside BC10, BB10, BB20, BT10, BPC-157. Keep each combination tied to a defined research objective and lot record.

Compliance notice

BBKG80 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. Reference context combines TB-500 tissue repair, BPC-157 regenerative signaling, KPV inflammatory-pathway literature, and GHK-Cu collagen and wound-model literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu).

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL bacteriostatic water for about 26.7 mg/mL. Component concentrations are TB-500, BPC-157, and KPV about 3.33 mg/mL each, with GHK-Cu about 16.7 mg/mL. Reference amount is about 2.67 mg daily for 4 weeks; 1 U is about 2.67 mg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL bacteriostatic water for about 26.7 mg/mL. Component concentrations are TB-500, BPC-157, and KPV about 3.33 mg/mL each, with GHK-Cu about 16.7 mg/mL. Reference amount is about 2.67 mg daily for 4 weeks; 1 U is about 2.67 mg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8 deg C, or -20 deg C for long-term storage. Reconstituted: 2-8 deg C, use within about 4 weeks, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Blend safety data is limited compared with single materials. Review every component and keep adverse observations separated by study arm.

Contraindications

Do not use BBKG80 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Avoid additional repair or anti-inflammatory stacks unless the protocol explicitly justifies each component.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps BBKG80 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: BBKG80
  • Product: TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg
  • Storefront specification: 80mg x 10 vials /box
  • LPPeptide reference specs: 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu)
  • Listed box price: $205.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is BBKG80?

Four-peptide repair blend profile with anti-inflammatory KPV. The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg is mapped to LPPeptide SKU BBKG80. Current storefront values use our product data: 80mg x 10 vials /box, $205.00 USD per box. LPPeptide reference specs: 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu).

Research context

The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. Reference context combines TB-500 tissue repair, BPC-157 regenerative signaling, KPV inflammatory-pathway literature, and GHK-Cu collagen and wound-model literature.

Commonly matched with

BBKG80 is commonly reviewed alongside BC10, BB10, BB20, BT10, BPC-157. Keep each combination tied to a defined research objective and lot record.

Compliance notice

BBKG80 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes KLOW as an 80 mg blend containing TB-500 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg. The source positions TB-500 for wound healing and angiogenesis, BPC-157 for regeneration, KPV for NF-kB inflammatory signaling, and GHK-Cu for collagen and tissue repair. Reference context combines TB-500 tissue repair, BPC-157 regenerative signaling, KPV inflammatory-pathway literature, and GHK-Cu collagen and wound-model literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu).

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL bacteriostatic water for about 26.7 mg/mL. Component concentrations are TB-500, BPC-157, and KPV about 3.33 mg/mL each, with GHK-Cu about 16.7 mg/mL. Reference amount is about 2.67 mg daily for 4 weeks; 1 U is about 2.67 mg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL bacteriostatic water for about 26.7 mg/mL. Component concentrations are TB-500, BPC-157, and KPV about 3.33 mg/mL each, with GHK-Cu about 16.7 mg/mL. Reference amount is about 2.67 mg daily for 4 weeks; 1 U is about 2.67 mg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8 deg C, or -20 deg C for long-term storage. Reconstituted: 2-8 deg C, use within about 4 weeks, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Blend safety data is limited compared with single materials. Review every component and keep adverse observations separated by study arm.

Contraindications

Do not use BBKG80 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Avoid additional repair or anti-inflammatory stacks unless the protocol explicitly justifies each component.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps BBKG80 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: BBKG80
  • Product: TB 10mg+BPC10 mg+KPV 10mg+GHK 80mg
  • Storefront specification: 80mg x 10 vials /box
  • LPPeptide reference specs: 80mg x 10 vials (TB-500 + BPC-157 + KPV + GHK-Cu)
  • Listed box price: $205.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.